The current study's goal was to determine the bone homeostasis balance in Iraqi post-COVID-19 patients and to identify the effect of the viral infection on both osteoclastogenesis and osteoblastogenesis by detecting the change in OPG levels in their blood. The gene discussed is TNFRSF11B; the disease is COVID-19.